What Wall Street Expects From These 3 Food Giants After Mixed Earnings

Conagra Brands (NYSE: CAG), Cal-Maine Foods (NASDAQ: CALM), and Lamb Weston (NYSE: LW) all reported Q3 FY2026 earnings on April 1, 2026, and Wall Street’s verdict is split: Cal-Maine is the relative bright spot, Lamb Weston faces genuine skepticism despite a headline beat, and Conagra sits under direct analyst pressure with a price target below current trading levels.

Conagra: TD Cowen Sets the Ceiling Below the Floor

TD Cowen holds a price target of $14 on Conagra, while the stock closed at $15.52 on April 1. That target implies further downside from a stock already down 41.7% over the past year. The earnings report did little to shift that view. Adjusted EPS came in at $0.39, missing the $0.40 consensus estimate and falling 23.5% year-over-year.

Management narrowed FY2026 adjusted EPS guidance to approximately $1.70, the low end of the prior $1.70 to $1.85 range. With cost of goods sold (COGS) inflation running approximately 7%, including tariff exposure, and adjusted gross margin compressed 112 basis points to 23.7%, the profitability trajectory that concerns analysts remains intact. CEO Sean Connolly cited “operational agility and relentless focus on cash” as stabilizing forces, and free cash flow conversion was raised to approximately 105%. However, that positive signal has not moved the institutional price target needle.

Lamb Weston: The Beat Wall Street Didn’t Believe

Lamb Weston delivered a headline EPS beat, with adjusted diluted EPS of $0.72 against a $0.61 estimate, a 17.42% surprise. The stock fell 8.9% on April 1 and is now down 27.8% over the past year. The reason is visible in the GAAP numbers: GAAP net income fell 63% year-over-year to $54 million, operating income dropped 49.1%, and gross profit declined 21.51%. The adjusted EPS figure excluded $55.5 million in restructuring charges and a $32.5 million raw potato write-off in the International segment. North America was a bright spot, with 12% volume growth, but price/mix fell 7% at constant currency as consumers shifted toward value channels.

Management raised the FY2026 net sales midpoint and tightened adjusted EBITDA guidance to $1.08 billion to $1.14 billion, and CEO Mike Smith stated the company expects to exceed its cost reduction target of at least $250 million by fiscal year-end 2028. Institutional money read the underlying margin deterioration as the more durable signal.

Cal-Maine: The Clearest Beat, With a Structural Caveat

Cal-Maine produced the strongest surprise of the three. Diluted EPS of $1.06 beat the $0.78 estimate by 35.9%, and the stock rose 5.5% on April 1 to $83.36. Some analysts view the stock as undervalued after its 4.73% one-month pullback.

The beat is notable because it came despite shell egg selling prices falling 56.5% year-over-year, validating the company’s mix-shift strategy. Specialty eggs now represent 50.5% of shell egg sales, up 2,610 basis points year-over-year, and combined specialty and prepared foods account for 52.9% of net sales. Cash and equivalents reached $1.152 billion, up 131.66% year-over-year, while total liabilities fell 37.74%. However, there is near-term risk, as highly pathogenic avian influenza (HPAI) affected flocks again in March 2026.

What This Means for Retail Investors

Across all three names, the macro backdrop adds pressure. University of Michigan Consumer Sentiment stood at 53.3 in March 2026, well within pessimistic territory below the 80 threshold, reinforcing the value-channel dynamics and volume pressure visible in each report. For Conagra, the TD Cowen target sitting below current price is a direct institutional signal that the stock has not yet found its floor. For Lamb Weston, the post-earnings sell-off reflects institutional conviction that adjusted earnings are masking structural margin erosion. And for Cal-Maine, the beat-and-rally pattern, combined with a strong balance sheet and disciplined capital return, positions it as the most credible near-term institutional thesis of the three, contingent on HPAI not escalating further.